Research Article: The Safety and Efficacy of Hepatic Arterial Infusion Chemotherapy Combined with PD-(L) Inhibitors and Molecular Targeted Therapies for the Treatment of Intermediate and Advanced Hepatocellular Carcinoma Unsuitable for Transarterial Chemoembolization
Introduction:
Hepatocellular carcinoma (HCC) is a lethal tumor that is highly prevalent worldwide, particularly in China, accounting for .% liver cancer cases globally, and it predominantly has a hepatitis B virus infection background predominantly. , Despite improvements in early detection, the majority of patients with HCC are diagnosed at an advanced stage, with limited options for radical treatment and dismal prognosis.
Read more